Trials / Terminated
TerminatedNCT01197482
Inhaled Steroids and Control of Severe Asthma
Inhaled Steroids and Control of Severe Asthma: Comparison of the AKITA Technology Versus Conventional MDI (INHALE)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- University of Giessen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Investigational device: AKITA 2 device versus conventional metered-dose inhaler (MDI) Objectives: To explore if inhalative fluticasone application by means of the AKITA technology would result in a better symptom control in patients with severe persistent asthma as compared to inhalative application of fluticasone by a conventional MDI. Study design: open label, cross-over (one AKITA, one MDI arm) Patients: 20 Patients with severe persistent asthma
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2018-12-28
- Completion
- 2018-12-28
- First posted
- 2010-09-09
- Last updated
- 2020-11-10
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01197482. Inclusion in this directory is not an endorsement.